Sources · 208 listed
Sources behind the answers.
Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.
Showing 21–40 of 208 sources
Source types explained
Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.
Tirzepatide once weekly for the treatment of obesity
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
July 2026 PCAC briefing on BPC-157-related bulk drug substances
Certain bulk drug substances for use in compounding that may present significant safety risks
BPC-157 as an investigational peptide therapeutic: translational development barriers
Safety of intravenous infusion of BPC157 in humans: a pilot study
Promoting effect of BPC 157 on tendon healing: tendon outgrowth, cell survival, and migration
2026 prohibited list
BPC 157 for acute hamstring muscle strain repair
Prolonged GH and IGF-1 stimulation by CJC-1295 in healthy adults
Pulsatile GH secretion during continuous stimulation by CJC-1295
CJC-1295 pharmacy compounding advisory review
Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers
Randomized proof-of-concept study of ipamorelin for postoperative ileus
VICTOZA (liraglutide) prescribing information
SAXENDA (liraglutide) prescribing information
Liraglutide and cardiovascular outcomes in type 2 diabetes
LY3437943 in people with type 2 diabetes: a phase 1b randomized trial
Retatrutide for people with type 2 diabetes: a phase 2 randomized trial
About this list
How this list works
This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.